These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24481346)

  • 1. New AHA-ACC guidelines could lead to major changes in clinical practice.
    Rosenberg K
    Am J Nurs; 2014 Feb; 114(2):13. PubMed ID: 24481346
    [No Abstract]   [Full Text] [Related]  

  • 2. A focus on cardiovascular risk modification: clinical significance and implementation of the 2013 ACC/AHA cholesterol guidelines.
    Kelly SC; Gonzalo R; Petrasko M
    S D Med; 2014 Aug; 67(8):320-3. PubMed ID: 25163226
    [No Abstract]   [Full Text] [Related]  

  • 3. Population and economic impact of the 2013 ACC/AHA guidelines compared with European guidelines to prevent cardiovascular disease.
    Vaucher J; Marques-Vidal P; Preisig M; Waeber G; Vollenweider P
    Eur Heart J; 2014 Apr; 35(15):958-9. PubMed ID: 24569030
    [No Abstract]   [Full Text] [Related]  

  • 4. ACP Journal Club. ACC/AHA, Adult Treatment Panel III, and ESC guidelines overestimated risk for CVD in older adults.
    Vaishnava P; Eagle KA
    Ann Intern Med; 2014 Aug; 161(4):JC13. PubMed ID: 25133380
    [No Abstract]   [Full Text] [Related]  

  • 5. Applicability of the 2013 ACC/AHA Risk Assessment and Cholesterol Treatment Guidelines in the real world: results from a multiethnic case-control study.
    Magnoni M; Berteotti M; Norata GD; Limite LR; Peretto G; Cristell N; Maseri A; Cianflone D
    Ann Med; 2016; 48(4):282-92. PubMed ID: 27052543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A perspective on the New American College of Cardiology/American Heart Association guidelines for cardiovascular risk assessment.
    Kullo IJ; Trejo-Gutierrez JF; Lopez-Jimenez F; Thomas RJ; Allison TG; Mulvagh SL; Arruda-Olson AM; Hayes SN; Pollak AW; Kopecky SL; Hurst RT
    Mayo Clin Proc; 2014 Sep; 89(9):1244-56. PubMed ID: 25131696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins: new American guidelines for prevention of cardiovascular disease.
    Ridker PM; Cook NR
    Lancet; 2013 Nov; 382(9907):1762-5. PubMed ID: 24268611
    [No Abstract]   [Full Text] [Related]  

  • 8. Comment on the reports of over-estimation of ASCVD risk using the 2013 AHA/ACC risk equation.
    Muntner P; Safford MM; Cushman M; Howard G
    Circulation; 2014 Jan; 129(2):266-7. PubMed ID: 24334111
    [No Abstract]   [Full Text] [Related]  

  • 9. Response to Comment on the reports of over-estimation of ASCVD risk using the 2013 AHA/ACC risk equation.
    Cook NR; Ridker PM
    Circulation; 2014 Jan; 129(2):268-9. PubMed ID: 24334112
    [No Abstract]   [Full Text] [Related]  

  • 10. Managing hyperlipidemia. The updated cholesterol treatment guidelines.
    Scordo KA
    Nurse Pract; 2014 Jul; 39(7):28-32; quiz 32-3. PubMed ID: 24878833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [European guidelines for lipid treatment are tailored according to risk level].
    Wiklund O
    Lakartidningen; 2012 Sep 19-26; 109(38):1653. PubMed ID: 23094394
    [No Abstract]   [Full Text] [Related]  

  • 12. Questioning the benefits of statins.
    Mazowita G
    CMAJ; 2005 Nov; 173(10):1210; author reply 1210. PubMed ID: 16275979
    [No Abstract]   [Full Text] [Related]  

  • 13. Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease.
    Robson J
    Heart; 2008 Oct; 94(10):1331-2. PubMed ID: 18701534
    [No Abstract]   [Full Text] [Related]  

  • 14. Statins: new US guideline sparks controversy.
    Lancet; 2013 Nov; 382(9906):1680. PubMed ID: 24267985
    [No Abstract]   [Full Text] [Related]  

  • 15. Statins in the elderly: what evidence of their benefit in prevention?
    Steg PG; Tissot CM
    Arch Cardiovasc Dis; 2010 Feb; 103(2):61-5. PubMed ID: 20226424
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of controversial ACC/AHA guidelines for statin therapy is supported by US studies.
    McCarthy M
    BMJ; 2015 Jul; 351():h3902. PubMed ID: 26194997
    [No Abstract]   [Full Text] [Related]  

  • 17. Understanding the role of big data in the CV risk calculator controversy.
    Smith A
    Am J Manag Care; 2014 Jan; 20(1 Spec No.):E1. PubMed ID: 25618227
    [No Abstract]   [Full Text] [Related]  

  • 18. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management--2005.
    Tonkin A; Barter P; Best J; Boyden A; Furler J; Hossack K; Sullivan D; Thompson P; Vale M; Cooper C; Robinson M; Clune E; ;
    Heart Lung Circ; 2005 Dec; 14(4):275-91. PubMed ID: 16361000
    [No Abstract]   [Full Text] [Related]  

  • 19. Interview: role of managed care in implementing NCEP-ATP III guidelines.
    Carver JC
    Am J Manag Care; 2002 Jul; Suppl Symposium Reporter():7. PubMed ID: 12608153
    [No Abstract]   [Full Text] [Related]  

  • 20. New ACC-AHA cholesterol guidelines significantly increase potential eligibility for statin treatment.
    Bittner V
    Evid Based Med; 2014 Oct; 19(5):198. PubMed ID: 25009052
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.